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rheal disease is a major cause of morbidity and mortality in infants
and children worldwide. Evidence suggests that the interaction of
immature human enterocytes with bacteria and their enterotoxins may
account for the increased susceptibility of neonates to diarrheal
diseases. However, the precise mechanisms that contribute to the
excessive response to cholera toxin by the immature gut are largely
unknown. Our aim was to characterize the cellular/molecular changes
in Gs during gut development. In this study, a colonic human
epithelial cell line (T84) was used as representative of a mature
enterocyte and a human fetal primary small intestinal cell line (H4) as
representative of an immature enterocyte. Using our cell culture
model of human intestinal development, we provide consistent evi-
dence that cholera toxin (CT)-mediated Gs activation in fetal entero-
cytes differs from that of mature enterocytes, and the difference may
be related to ADP-ribosylation factor (ARF) interaction with the
CT-signaling process. Here we demonstrated that ARF1 may play a
critical role in clathrin-mediated CT trafficking through the endoplas-
mic reticulum and Golgi and that ARF6 may facilitate clathrin-
mediated CT endocytosis that leads to enhanced Gs activation by
CT. Collectively, these findings support our hypothesis that there is a
developmentally regulated intestinal cellular response to bacterial
exotoxins involving complex cellular events that accounts for the
increased incidence and severity of toxogenic diarrhea during infancy.
cholera toxin trafficking; developmental cholera toxin-Res; stimula-
tory guanine nucleotide binding protein-
CHOLERA TOXIN (CT) is a pentavalent protein comprised of five
binding (B) subunits that interact with an enterocyte microvil-
lus glycolipid ganglioside (GM1) and one active (A) subunit
with enzymatic activity that is capable of ADP-ribosylation of
the -subunit of a heterotrimeric guanine nucleotide-binding
(G) protein Gs (Gs) (16). In polarized epithelial cells, the
activation of signal transduction by CT requires endocytosis of
the toxin-receptor complex into the apical endosome, its trans-
location by retrograde transport into the Golgi cisternae or
endoplasmic reticulum (ER), and finally the movement of the
toxin to its site of action in the basolateral membrane (reviewed
in Refs. 18, 21, 37).
CT exerts its effect on intestinal cells via ADP-ribosylation
of the -subunit of a heterotrimeric guanine nucleotide binding
(G) protein Gs, the stimulatory G protein for adenylate cyclase
(AC). After ribosylation, Gs remains activated and causes a
100-fold increase in cAMP production (37), which can lead to
excessive chloride secretion and a severe secretory diarrhea in
humans (9).
The discovery of CT and its mechanism of interaction with
the enterocyte as a prototypic bacterial exotoxin has yielded
vital information about the pathophysiology of toxogenic di-
arrhea and CT intracellular signal transduction steps, including
the role of G proteins in excessive chloride secretion (18, 19,
38). These studies have led to the discovery and characteriza-
tion of a family of small GTP-binding proteins called ADP-
ribosylation factors (ARFs) named for their ability to enhance
the CT-catalyzed ADP-ribosylation of Gs as an allosteric
activator of the toxin (29, 30). In addition, ARFs have been
recently recognized to play a critical role in vesicular mem-
brane trafficking (30).
There is increasing evidence that an immature enterocyte
interaction with bacteria may, in part, explain the increased
susceptibility of neonates to infectious diarrhea (4, 14, 40).
This laboratory has studied the excessive secretory response to
CT in animal models and has concluded that the principal
mechanism is mediated by a developmentally regulated inap-
propriate postreceptor response (5, 20, 41, 43). For example, a
previous study has shown that Gs expression is upregulated in
preweaned compared with postweaned and adult rat entero-
cytes (41). This developmental change in Gs might be a key
factor in mediating the excessive secretory response to CT in
the young rat (41).
Recently we have extended these observations to experimen-
tal models of human intestinal development (23, 25). In these
studies, we have also provided evidence that CT induces an
enhanced secretory reaction mediated in part by a developmen-
tal upregulation of the cAMP response in immature vs. mature
human enterocytes (23), and this enhanced response to CT is
largely due to an excessive uptake of CT by a developmentally
regulated clathrin-endocytic pathway (25). In this study, we
examined the cellular/molecular basis for CT signaling in the
developing human gut and provide evidence that ARFs are
involved.
MATERIALS AND METHODS
Materials. CT was purchased from Calbiochem (EMD, La Jolla,
CA). Anti-clathrin heavy-chain (Cla-HC) antibody (mAb) was pur-
chased from BD Transduction Laboratories (Palo Alto, CA). Anti-Gs
and anti-G-complex rabbit pAb (anti-G) were obtained from
Calbiochem. Anti-ARF1 and 6 mAb were obtained from Abcam
(Cambridge, MA). Anti-CT-A and B polyclonal antibodies were
obtained from Dr. Wayne Lencer’s Laboratory (Children’s Hospital,
Boston, MA). Horseradish peroxidase-conjugated goat anti-mouse
and anti-rabbit antibodies are from Bio-Rad (Hercules, CA). Hema-
glutinin (HA)-tagged full-length ARF1 and ARF6 plasmids were kindly
provided by Dr. Jim Casanova (Department of Cell Biology, University
xof Virginia, Charlottesville, VA). [32P]NAD was obtained from
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PerkinElmer (Waltham, MA). ARF inhibitory peptide (ARFI) was
obtained from Biomol (Plymouth Meeting, PA). Human recombinant
EGF, Trizol, SuperScript III Platinum SYBR Green One-Step qRT-
PCR kits, Stealth siRNA duplex oligoribonucleotides for ARF1, 3, 4
and 6, and lipofectamine RNAi MAX were obtained from Invitrogen
(Carlsbad, CA). All tissue culture media and reagents are obtained from
Invitrogen-GIBCO. All other chemicals unless specified were pur-
chased from Sigma-Aldrich (St. Louis, MO).
Cell cultures. H4 (fetal) and T84 cells (adult) were used in this
study. H4 cells have been used as an immature human intestine model
in previous studies (6, 25, 31, 39). H4 cells were routinely maintained
in DMEM supplemented with 10% FBS and human recombinant
insulin (0.5 U/ml). In selected experiments, H4 cells were preincu-
bated in H4 media containing 1 M hydrocortisone (HC) for 5–7 days
(H4/HC) before further treatment. T84, a well-characterized and
highly differentiated human colon carcinoma cell line, has been used
as a mature human intestinal model (6, 25, 31, 39). T84 cells
(American Type Culture Collection, Rockville, MD) were maintained
in DMEM-F12 Ham with 5% FBS. Cells were seeded on either
12-mm (24-well) or 33-mm (6-well) tissue culture plates or permeable
inserts. T84 cells, grown on permeable inserts, were used when they
became confluent and formed polarized monolayers and tight junc-
tions (e.g., resistance   1000). In some experiments, T84 cells,
grown on permeable inserts, were used before cells reached conflu-
ence (subconfluent,   100). These cells have neither formed tight
junctions nor polarized monolayers. CT was used at a 20 nM concen-
tration (dose range 0.2–20 nM). All CT-stimulation experiments were
done in serum-free HBSS supplemented with 0.25% bovine albumin.
Determination of the developmental Gs and ARF gene expression.
The level of Gs and ARF mRNA was measured in duplicate for each
sample by quantitative RT-PCR (qRT-PCR) using a SYBR Green
One-Step qRT-PCR kit. The level of Gs and ARF mRNA expression
was normalized to the standard GAPDH level for each sample.
Determination of CT-catalyzed ADP-ribosylation of Gs. In vitro
[32P]ADP-ribosylation was carried out in H4 and T84 cell lysates
using the method described by McKenzie (27). Briefly, H4 and T84
cells were harvested in lysis buffer containing 0.5% SDS. A sample
(20 g) of cell lysates was assayed in a 50-l volume containing
[32P]NAD (3 M, 4  106 counts/min), potassium phosphate buffer
(250 mM, pH 7.0), thymidine (20 mM), ATP (1 mM, pH 7.0),
arginine hydrochloride (20 mM), and 100 M GTP. CT was activated
by incubation with 50 mM DTT for 60 min at room temperature and
then added to the mixture at a final concentration of 50 g/ml. The
assay was carried out in a water bath at 37°C for 60 min and
terminated by transfer to ice. Next, after in vitro ADP-ribosylation, the
samples were prepared for SDS-PAGE by sodium deoxycholate/
trichloroacetic acid precipitation as detailed elsewhere (27) and visu-
alized by autoradiograph. In selected experiment, 100 g of fresh rat
brain extract was added to the sample before the assay was carried out
as described above.
Immunoprecipitation, SDS-PAGE, and Western blot (immunoblot
analysis). After experiments were completed, cells were rinsed with
HBSS. Surface-bound toxin was removed with acidified HBSS (pH
2.5). Cells were lysed in Tris-buffered solution (4°C) containing 1%
Triton X-100 (1% TTBS), 0.5% SDS, and protease inhibitors as
described previously (25). In some experiments, Triton-soluble pro-
teins were collected first, and the insoluble fraction was then collected
in 1% TTBS containing 0.5% SDS. Both fractions (10 g proteins)
were analyzed by SDS-PAGE (4–20% linear gradient gel) and West-
ern blotting. For immunoprecipitation, H4 and H4/HC cells were
transfected with HA-tagged ARF1 and ARF6 expression vectors as
well as the vector alone as a control. Seventy-two hours after trans-
fection, cells were washed with HBSS() and then harvested in lysis
buffer containing 50 mM Tris, pH 7.5, 150 mM NaCl, 1.0% Nonidet
P-40, 10% glycerol, 0.5 mM PMSF, and a complete protease inhibitor
tablet (Roche) and then extracted for 15 min on ice. Cell lysates were
then incubated for 2 h (4°C) with monoclonal anti-HA antibody (1
g/IP) to allow for binding of antibody to antigen. After incubation,
30 l (	50% slurry) of protein A Sepharose beads (Santa Cruz
Biotechnology, Santa Cruz, CA) to the lysate and incubated on a
rotating device at 4°C for 60 min. The protein A beads were collected
by spinning briefly and washed with lysis buffer four times before
mixing with SDS sample buffer containing reducing agent. The
mixture was then boiled for 3–5 min before SDS-PAGE and Western
blot analysis.
Briefly, lysates were resolved on a 4–20% linear gradient poly-
acrylamide gel and transferred onto nitrocellulose membranes. After
being blocked with 5% nonfat milk solution, membranes were se-
quentially probed with appropriate dilution of primary (1:1,000) and
secondary antibodies (1:5,000) and visualized by enhanced chemilu-
minescence (Bio-Rad). GAPDH was used as a housekeeping protein
to control for equivalent loading.
Sucrose equilibrium density centrifugation. Confluent monolayers
of T84, H4, and H4/HC cells were used for isolation of detergent-
insoluble glycolipid/rafts. All steps were completed at 4°C as de-
scribed in detail elsewhere (2, 50). Briefly, cells were lysed in 1%
Triton X-100 (1% TBS) and homogenized with 15 strokes in a
Dounce homogenizer on ice. The subsequent homogenates were
adjusted to a 40% sucrose concentration with an equal volume of 80%
sucrose in TBS, layered under a linear 5–30% or discontinuous
sucrose gradient, and centrifuged at 39,000 revolution/min for 16–20
h in a swinging bucket rotor (model SW 41). Ten fractions were
collected sequentially from the top, and 20 l of each fraction was
analyzed by SDS-PAGE and Western blotting.
RNA interference. H4 and H4/HC cells were plated on 6- or 24-well
plates at an optimal density and then transfected with small interfer-
ence RNA (siRNA) using lipofectamine (Invitrogen). ARF1, ARF3,
ARF4, and ARF6 (stealth select, Invitrogen) and a scrambled control
siRNA (at a dose range 0.1–100 nM for initial study and optimal
concentration afterward) were used in selected experiments. After
transfection, cells were incubated for 48–72 h before further study.
Expression of HA-ARF1 and 6 DNA. The expression vector (1 g
DNA) containing full-length HA-tagged ARF1 and ARF6 as well as
vector alone were transfected into H4, H4/HC, and T84 cells using
lipofectamine agent LTX according to manufacturer’s recommenda-
tion. Seventy-two hours after transfection, cells were exposed to CT
or EGF before cell lysates were harvested for cAMP and Western blot
analysis.
Enzyme immunoassay. We used cAMP levels as the functional
indicator for the CT response in this study. Enzyme immunoassays
(EIAs) were used to measure cAMP levels as described previously (23).
Statistical analysis. Data were analyzed by two-sided Student’s
t-test using Microsoft Excel and expressed as means
 SE (n 4–6).
RESULTS
Differential expression and activation of Gs. Previous stud-
ies from our laboratory demonstrated that there is an increase
in Gs mRNA expression and an excessive Gs ribosylation in
preweaned compared with postweaned rat enterocytes (41).
However, little is known about the gene expression and regu-
lation of Gs in human enterocytes. Before investigating the
cellular mechanism for CT activation of Gs, we examined its
expression in H4 vs. T84 cells. No significant difference was
noted in Gs mRNA expression between H4 and T84 cells.
Real-time, semi-quantitative PCR indicated that Gs mRNA is
highly expressed in both cells, but the expression level is
slightly higher in T84 compared with H4 (Fig. 1A). Next, we
examined the cellular distribution of Gs. In H4 cells, Gs is
present principally in the detergent-soluble membrane (non-
raft) fraction, whereas in T84 cells Gs is largely present in the
detergent-insoluble and lipid raft-associated membrane frac-
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tions (Fig. 1B). In addition, Gs protein levels were higher in
T84 compared with H4 cells in both cellular fractions (Fig.
1C). However, after CT exposure, Western blot analysis dem-
onstrated a higher CT-induced Gs activation in H4 compared
with T84 cells, as indicated by a slower migration of the
45-kDa Gs isoform on a 4–20% linear gradient SDS-PAGE
gel attributable to the ADP-ribosylation of Gs (Fig. 1C,
arrow). It is hypothesized that Gs activation is necessarily
accompanied by subunit dissociation in situ. We next com-
pared the G cellular distribution after CT intoxication in H4
vs. T84 cells. In H4 and T84 cells, G was principally
localized in the detergent-soluble membrane fraction. Further-
more, upon CT exposure, there was a decrease of membrane-
associated G in H4 cells but not in T84 cells (Fig. 1D).
Previously, we have shown a CT-induced excessive cAMP
response in immature human enterocytes, indicating an exces-
Fig. 1. Heterotrimeric G protein distribution and
activation in H4 vs. T84 cells. A: real-time PCR of
Gs mRNA expression in H4, T84, and H4/hy-
drocortisone (HC) cells normalized by GAPDH
expression. B: Western blots (4–20% gel) depict-
ing Gs protein distribution on a sucrose gradient
(5–30%) column probed with an anti-Gs (COOH
terminus) antibody (1:1,000 dilution). Fractions
4–7 (box) are lipid-raft fractions. C: in H4 cells
Gs is present principally in Triton X-100-soluble
membrane fraction, whereas in T84 cells Gs is
largely present in Triton X-100-insoluble fraction.
Cholera toxin (CT)-induced activation of Gs dif-
fers in H4 vs. T84 cells (the arrow indicates a
retarded migration of Gs isoform) (45 kDa) on
SDS-PAGE (4–20% linear gradient gel) attribut-
able to ADP-ribosylation. Ctrl, control. D: West-
ern blot analysis of G in H4 vs. T84 cells probed
with an anti-G complex pAB (1:1,000). G is
present principally in Triton X-100-soluble mem-
brane fraction in both H4 and T84 cells. After CT
exposure, G is dissociated from the membrane
fractions in H4 cells in a time-dependent manner,
but this is absent in T84 cells.
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sive activation of AC (23). We have also shown that immature
enterocytes have a significantly higher rate of CT endocytosis
compared with mature enterocytes, and this may contribute to
the excessive CT-catalyzed Gs activation in these cells (25).
We next investigated in T84 cells the CT dose responsiveness
under subconfluent (nonpolarized) and confluent (polarized)
conditions and compared this response to that in H4 cells with
or without HC. Polarized T84 cells can form tight junctions
and thus separate the apical from basolateral surface, whereas
subconfluent T84 cells are not polarized and are thus without
apical and basolateral segregation. This is similar to the con-
dition of cultured H4 cells. As shown in Fig. 2, subconfluent,
nonpolarized T84 cells demonstrated a significantly higher CT
uptake than confluent, polarized T84 cells. However, there was
no significant difference in the CT-induced cAMP response
between these two cell types. This result is consistent with a
previous report that, when CT is applied basolaterally, T84
cells demonstrated a higher CT uptake but not a greater
secretory response compared with apical application of CT
(19). In contrast, HC-treated H4 cells demonstrated a lower
rate of CT uptake and a significantly lower cAMP response
than H4 cells alone.
Other factors that modulate CT activation of Gs. First,
using an in vitro ADP-ribosylation assay, we examined CT-
catalyzed Gs ribosylation in H4 and T84 cells compared with
that reported for pre- and postweaned rat small intestinal
enterocytes. Consistent with the previous report (41), we found
significantly more Gs ribosylation in pre- compared with
postweaned and adult rat enterocytes (data not shown). How-
ever, using cell lysates in a cell-free ribosylation assay, we
were unable to detect Gs ribosylation in H4 cells, whereas we
were able to observe a ribosylation of Gs in T84 cells. These
observations suggested that the CT-A subunit is capable of
ADP-ribosylation of substrate analogs in vitro. However, it has
been known that a number of additional membrane proteins
and intracellular factors are needed to promote or augment the
enzymatic activity in vivo (35). Accordingly, we next investi-
gated whether the addition of rat brain extract that is enriched
with ADP-ribosylation factors could facilitate ADP-ribosyla-
tion of Gs as described in Ref. 29. Increased levels of
Gs-ribosylation in H4 and T84 (to a lesser degree) cells were
noted when rat brain extract was added to the assay mixture
(Fig 3A). This result suggested that cytosolic/membrane factors
in rat brain extract facilitated the CT-mediated ADP-ribosyla-
tion of Gs in immature human enterocytes. Since newly
identified ARFs have been known to facilitate ADP-ribosyla-
tion of Gs by CT in live cells (35), we next began to examine
the role of ARFs in the CT response in H4 vs. T84 cells.
To examine whether ARFs were involved in the CT re-
sponse, we used an ARFI to block its function. We observed
that the ARF inhibitor significantly diminished the CT-induced
cAMP response in H4 cells but not in T84 cells, suggesting a
possible role of ARFs in mediating the CT response in imma-
ture enterocytes (Fig. 3B). In mammalian cells, there are six
known ARF isoforms, which belong to three classes: ARF1, 2,
and 3; ARF 4 and 5; and ARF6. To identify which class/classes
ARFs were involved in CT activation of Gs, we transfected
H4 and T84 cells with siRNAs targeting human ARF genes 1,
3, 4, and 6 before exposure to CT. As shown in Fig. 3C, a
knockdown of ARF1 and ARF6 significantly inhibited the
CT-induced cAMP response in H4 but not in T84 cells. In
contrast, neither ARF3 nor ARF4 knockdowns exhibited an
effect on the CT response in either cell (Fig. 3C). Our RT-PCR
data indicated that there is little ARF3 and ARF4 expression
compared with ARF1 and 6 expression in H4 and T84 cells
(Fig. 3D), and this might be the reason that we were not able
to observe any difference in ARF3/4 knockdown experiments.
We next examined whether ARFs play a role in either CT
uptake or Gs activation in H4 cells. Western blot analysis
demonstrated that knockdown of ARF1 or ARF6 using siRNA
blocked CT-catalyzed ADP-ribosylation of Gs compared with
cells either maintained in media alone or transfected with
control (scrambled) siRNA (Fig. 4). In these experiments, we
demonstrated that knockdown of ARF1 and 6 proteins by
siRNA (shown in Fig. 4A) downregulated CT-mediated Gs
activation. This is indicated by an absence of retarded migra-
tion of the 45-kDa Gs isoform on the Western blot as shown
in Fig. 4B. In addition, knockdown of ARF6 also decreased CT
uptake in H4 cells. In contrast, transfection of ARF1 siRNA
had no effect on CT uptake (Fig. 4C).
ARFs have been shown to be involved in the formation of
clathrin-coated vesicles (44) and vesicular transport from the
ER to the Golgi (49). Accordingly, we next examined the
interaction of ARF1/ARF6 with the CT-endocytosis machin-
ery. H4 cells were transfected with a HA-tagged full-length
ARF1/ARF6 for 72 h before exposure to CT. Total cell lysates
were immunoprecipitated with an anti-HA antibody before
being fractionated on a SDS-PAGE and probed with an anti-
Cla-HC antibody. Western blot analysis showed a coprecipi-
tation of clathrin and ARFs in H4 cells that have been exposed
Fig. 2. CT dose responsiveness differs in im-
mature vs. mature enterocytes. A: cellular
accumulation of cAMP in response to differ-
ent doses of CT (0.1–100 nM) was monitored
in H4 cells with or without pretreatment with
HC and T84 cells under subconfluent and
confluent/polarized conditions. The results
are presented as picomoles per milligram total
cellular protein (pmol/mg). The data are rep-
resentative of 3 experiments. B: Western blot
analysis of CT uptake in H4 vs. T84 cells
under undifferentiated and differentiated con-
ditions. Western blot depicting an expected
11-kDa band (CTB) on a 10–20% SDS-
PAGE.
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to CT at 37°C (Fig. 5A). Since the EGF receptor (EGFR) is
known to be internalized via a clathrin-mediated endocytosis
upon ligand binding, we used EGFR endocytosis to examine
the specificity of ARFs in regulating CT endocytosis and
trafficking. As shown in Fig. 5B, there was no coprecipitation
of clathrin and ARFs in H4 cells that have been incubated with
EGF, suggesting that the ARF effect is specific for the CT
response.
Collectively, these data suggest that ARFs might affect the
CT response through complementary mechanisms, e.g., ARF1
had its effect principally on CT trafficking and signaling (Figs.
4B and 5A), whereas ARF6 plays a major role in CT endocy-
tosis (Figs. 4C and 5A).
In summary, the CT response via Gs signaling in fetal
enterocytes may differ from that of mature enterocytes, and the
difference may be related to ARF interaction with the CT-
signaling process.
HC affects CT activation of Gs in H4 cells. In a previous
study, we have shown that a known breast milk trophic factor,
HC, can alter the excessive secretory response to CT in
immature human fetal enterocytes (23) and can induce a
maturation change in endocytosis (25). We concluded that this
Fig. 3. The effect of ADP-ribosylation fac-
tors (ARFs) on the CT-induced cAMP re-
sponse in H4 vs. T84 cells. A: in vitro ADP
ribosylation of Gsa by CT in H4 vs. T84
cells. Cell lysates (25 g) were incubated
with -32P-NAD with CT or control. Black
arrows indicate the ribosylated Gs isoforms
(1, 2 and 3) at molecular weight of 42, 45,
and 52 kDa in T84 cells, but not seen in H4
cells. Addition of ARFs in rat brain extract
(Calbiochem) increased CT-catalyzed Gs ri-
bosylation in H4 and T84 cells. B: H4 and
T84 cells were pretreated with ARF inhibi-
tory peptide (ARFI) before CT exposure.
Cellular cAMP levels were measured and
presented as means 
 SE (n  6). C: ARF
knockdown affects the CT-induced cAMP
response in H4 but not in T84 cells. H4 and
T84 were transfected with siRNA targeting
ARF1, 3, 4, and 6 or control (scrambled
RNA) before CT exposure. Cellular accumu-
lation of cAMP was measured and expressed
as means 
 SE (n  6). Inset: knockdown
efficiency of ARF1 and ARF6 in H4 and T84
cells, respectively. ARF3 or ARF4 knock-
down had no effect on the CT response in H4
and T84 cells (real-time PCR cannot detect
ARF3/4 mRNA expression after siRNA
treatment). D: real-time PCR of ARF1, 3, 4,
and 6 mRNAs expression in H4 vs. T84 cells
normalized by GAPDH expression.
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change in CT endocytosis was partially attributable to a HC-
induced CT-GM1 lipid raft association through maturational
changes in the plasma membrane phospholipid composition of
immature enterocytes (24). In this study, we investigated
whether HC affected the developmental control of CT-induced
Gs activation. H4 cells were preincubated with HC (1 M) for
24 h or 5 days before CT exposure. As shown in Fig. 6A,
pretreatment of H4 cells in HC (H4/HC) induced a Gs lipid
raft association when fractionated on a 5–30% sucrose gradient
column. After H4/HC cells were challenged with CT, Western
blot analysis demonstrated a decrease in Gs activation only in
cells that have been pretreated with HC for 5 days compared
with H4 cells grown either in media or in HC for 24 h (Fig.
6B). This lack of activation was not due to a decrease in Gs
mRNA or protein expression. The gene expression analysis
and real-time RT-PCR in H4 cells preincubated with HC for
various lengths of time (12, 24, and 48 h to 7 days) demon-
strated a slight increase of mRNA expression after HC treat-
ment (Fig. 1A).
Next, we examined whether pretreatment of H4 cells with
HC (5–7 days) could affect the role of ARFs in the CT
response. We transfected H4/HC cells with siRNAs targeting
either ARF1 or ARF6. In contrast to data shown in Fig. 3B, HC
pretreatment diminished the ARF-dependent CT response mea-
sured as CT-induced cAMP production in these cells (Fig. 6C).
Western blot analysis demonstrated a sufficient knockdown of
ARF1/6 proteins in H4/HC cells (Fig. 6D).
DISCUSSION
CT is responsible for the devastating diarrheal syndrome
characteristic of cholera. CT-induced secretory diarrhea occurs
more commonly and severely in young infants than in older
children and adults. It is the best-characterized disease medi-
ated by the Gs/cAMP signaling pathway. Previous studies
from our laboratory have shown an increased cAMP response
to CT in the small intestine of suckling compared with mature
rats (43). This increased sensitivity of AC to CT is largely due
to higher Gs mRNA expression and increased ADP-ribosyla-
tion of one or both Gs isoforms in the preweaned rat small
intestine (41). We previously reported that immature human
enterocytes exhibit an excessive secretory response to CT, and
this response is, in part, due to a developmental difference in
CT endocytosis (25). However, little is known about the
developmental regulation of the CT signaling leading to Gs
activation in immature human enterocytes. In this study, we
have examined CT signaling via Gs activation and provide
evidence to suggest that the molecular basis for this develop-
mental change in host responsiveness might be related to a
difference in the CT-endocytosis machinery utilized by imma-
ture human enterocytes. In addition, we provide evidence for a
Fig. 4. Downregulation of ARF1 or ARF6 affects the CT response in H4 cells.
A: efficiency of ARF1/6 knockdown by siRNAs on Western blot. B: effect of
ARF1/6 knockdown on CT-induced Gs ribosylation in H4 cells. The black
arrows indicate the CT-catalyzed ribosylation of Gs isoform (45 kDa, up-
shifted) in H4 cells treated with either media alone or control siRNA. Dashed
arrows indicate lack of Gs isoform upshift in H4 cells transfected with either
ARF1 or ARF6 siRNA. C: effect of ARF1/6 gene knockdown on CT uptake
in H4 cells. Western blots depicting the expected 11-kDa band probed with
anti-CTB antibody (1:5,000).
Fig. 5. ARF1 and ARF6 interact with clathrin in the CT-mediated signaling process. H4 cells were transfected with hemaglutinin (HA)-tagged ARF1 and ARF6
expression vectors before being immune precipitated with an anti-HA antibody, resolved on SDS-PAGE, and probed with an anti-clathrin heavy-chain (Cla-HC) antibody
(1:1,000). A: coprecipitation of ARF1/6 with Cla-HC after CT exposure in H4 cells. A Western blot depicts an expected Cla-HC band at 180 kDa on a 4–20% linear
gradient gel. B: H4 cells were incubated with 100 ng of EGF. There is no EGF receptor-induced coimmunoprecipitation of ARF1/6 with clathrin.
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major role that ARF1/6 play in CT trafficking and signaling in
immature human enterocytes.
Gs is ubiquitously expressed in various tissues, and its
cellular distribution changes under a wide range of metabolic
conditions such as cellular differentiation, ontogenic develop-
ment, aging, and various adaptive processes (10, 11, 45). Here,
our results have shown a higher level of Gs protein expression
as well as in vitro CT-catalyzed ADP-ribosylation of Gs in
mature compared with immature enterocytes. However, this
observation was in contrast with the observed increase of Gs
ADP-ribosylation in intact H4 vs. T84 cells. This inconsistency
between cell-free and intact cell observations suggests that
additional factor(s) maybe involved in CT signaling leading to
Gs activation. Furthermore, we compared the difference in the
CT response in subconfluent vs. confluent (nonpolarized vs.
polarized) T84 cells. Interestingly, subconfluent T84 cells
showed an increase in CT uptake, yet no difference in the
CT-induced cAMP response compared with confluent cells.
This observation is in contrast to the observations made in H4
cells in which pretreatment with HC significantly decreased CT
uptake (25) and diminished the cAMP response, respectively.
Taken together, these data suggest that the observed difference
in the CT response between H4 and T84 cells is likely attrib-
utable to a posttranscriptional modification of Gs that leads to
its excessive activation.
Recent developments have provided interesting speculations
about the possible cellular or molecular basis for regulating CT
induced Gs signaling in developing human enterocytes. First,
compartmentalized (segregated) Gs may prevent CT access.
A striking enrichment of Gs in the Triton X-100-insoluble and
lipid-raft fraction of the cell membrane was found in T84 and
H4/HC cells, which was absent in H4 cells. Secondly, the
involvement of G subunits in Gs activation may differ. It
has been proposed that the G subunits are a membrane
anchor for Gs, and dissociation/release of G from Gs leads
to activation of AC and elevation of cAMP (15, 48). In a
cyc-s49 system, both Gs and G had to be present in the
membrane, and they had to be able to form a heterotrimer in
order for CT to ADP-ribosylate Gs (15). Moreover, it was
reported that G plays an important role in targeting Gs to
the plasma membrane and is essential for binding and activat-
ing of the heterotrimeric G proteins by receptors in HEK293
cells (12, 13). In H4 cells, G subunits were mostly present in
the Triton X-100-soluble membrane fraction similar to the
distribution of Gs (Fig. 1). We provide evidence that, upon CT
exposure, there was a decrease in membrane G and an
increase in CT-induced Gs activation in H4 cells. However, in
T84 cells G subunits were largely present in the Triton
X-100-soluble membrane fraction, a location segregated from
the lipid raft-associated Gs. In this manner, pretreatment of
H4 cells with HC can induce a maturational change in the
plasma membrane (24) and an increased lipid raft association
with Gs that results in a decreased CT response. These
observations suggest that in human fetal enterocytes the lack of
lipid-raft association might provide an easier access for CTA1
to interact with Gs. Furthermore, the association with G
subunits in the plasma membrane may facilitate the CT-
catalyzed ADP-ribosylation of Gs, leading to AC activation
and cAMP elevation. In contrast, in T84 cells, Gs proteins are
enriched in lipid rafts and segregated from G. This structure
might restrict the access of CTA1 to Gs, resulting in a reduced
CT response. However, further studies are needed to determine
whether interaction between Gs and G at the plasma mem-
brane and subsequent dissociation of G is important for Gs
activation and the CT response in human enterocytes.
CT-catalyzed ADP-ribosylation of Gs and activation of AC
are enhanced by a family of soluble or membrane factors
termed ARFs (35, 46). Previous studies have supported the
hypothesis that ARFs are allosteric activators of CTA1 (35).
However, recent studies have demonstrated that ARF proteins
are not only activators of CT but also critical components of
intracellular vesicular transport processes (30, 36). Here, we
provided evidence that ARF1 and as ARF6 are required for CT
uptake and signaling in human fetal enterocytes (Fig. 4). Both
ARF1 and ARF6 have been shown to participate in clathrin-
mediated vesicle trafficking events, but they function at dis-
tinctly different steps in membrane trafficking (3, 44). For
instance, ARF1 can function through the assembly of clathrin-
coated proteins in the ER/Golgi membrane, in ER-Golgi and
intra-Golgi transport, or in transport vesicles from the trans-
Golgi network (28, 42). In contrast, ARF6 can play an impor-
tant role in clathrin-mediated endocytosis (1, 33). Their func-
tion in membrane trafficking is the recruitment of membrane
coat proteins including coatomer protein (22), clathrin, and
Fig. 6. The intestinal trophic factor, HC, affects
the CT-mediated Gs response and ARF func-
tion in H4 cells. A: H4 cells were preincubated
with HC for 5 days, and Gs distribution was
examined on a sucrose gradient column (5–30%).
Fractions 4–7 contain lipid rafts. B: H4 cells
were pretreated with HC for 1 or 5 days before
CT exposure. A Western blot depicts the ex-
pected Gs isoforms probed with an anti-Gs
antibody. The black arrows indicate Gs ribosy-
lation (upshift of 45 kDa Gs isoform), and the
dashed arrows indicate a diminished Gs activa-
tion after preincubation with HC for 5 days.
Twenty-four-hour pretreatment has no effect on
the CT response in H4 cells. C: H4/HC (5 days)
cells were transfected with siRNA targeting
ARF1, ARF6, or control before CT exposure.
Intracellular cAMP elevation was measured and
expressed as means 
 SE. D: ARF1/6 gene
knockdown efficiency in H4/HC cells moni-
tored by Western blotting.
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clathrin adaptor proteins such as AP1, AP2, AP3, and AP4
complexes (17, 26, 32, 34). Some studies have shown that
ARFs can also activate phosphatidylinositol 4-phosphate 5-ki-
nase (PIP 5-kinase), an enzyme that generates PtdIns(4,5)P2
(3). Phosphoinositols [PtdIns(4,5)P2 and PtdIns(3,4,5)P3] have
been shown to affect clathrin-mediated membrane trafficking
(7, 8, 47). However, further studies are needed to clarify the
possible interactions between ARF6 and clathrin-coated vesi-
cles to elucidate the mechanism by which ARF6 regulates
clathrin-mediated vesicular trafficking either by being directly
involved in coat formation, by recruitment of clathrin adaptor
protein (such as AP2), or by interaction with phospholipids
particularly, PtdIns(4,5)P2 and PtdIns(3,4,5)P3.
ARF1 is required in both clathrin-dependent and -indepen-
dent vesicular transport in the Golgi (26). We have shown in
our preliminary results that ARF1 is required for CT-mediated
AC activation in H4 and to a lesser degree in T84 cells (Fig. 2)
because knocking down ARF1 expression in H4 cells resulted
in a significantly diminished CT-induced cAMP response with-
out affecting CT uptake. In contrast, there is only a slight
decrease of cAMP response in T84 cells. It has been reported
that ARF1 is required for the formation of clathrin-coated
vesicles at the Golgi level in cells, whereas ARF6 has been
involved in plasma membrane trafficking. This is consistent
with our findings that, in human fetal immature enterocyte,
ARF1 and ARF6 function at different levels in regulating
clathrin-dependent CT trafficking or endocytosis, respectively
(Figs. 4 and 5).
In this study, we show that an immature Gs response exists
in immature human fetal enterocytes leading to an excessive
AC activation and cAMP response. We provide evidence that
membrane/cellular factors, particularly ARF1 and ARF6, con-
tribute to a critical role in regulating clathrin-mediated CT
uptake, intracellular trafficking, and/or CT signaling in these
immature enterocytes. Moreover, we provide preliminary evi-
dence that trophic factors may modulate the immature Gs
response toward a more mature response. It is noteworthy that
in human enterocytes there is a developmental alteration in the
plasma membrane phospholipid content (24). A maturation of
plasma membrane lipid composition may result in compart-
mentalization and distribution changes in many cellular factors
such as heterotrimeric G proteins Gs and  subunits, as well
as ARF family proteins, leading to changes in CT endocytosis,
intracellular trafficking, and eventually in signal transduction
and effector responses. Collectively, these findings support our
hypothesis that there is a developmentally controlled intestinal
cellular response to bacterial exotoxins involving complex
cellular events. One caveat in interpreting our studies is that
T84 cells, which are an adult human colonic carcinoma epi-
thelial cell line, do not perfectly model normal mature entero-
cytes. Therefore, it would be inappropriate to use T84 cells as
a comparison for all factors that influence intestinal immatu-
rity. However, previous studies comparing intestinal develop-
ment in H4 cells and T84 cells have been validated in multiple
systems including suckling rats, xenografted human fetal small
intestine, and primary cultures of freshly isolated human small
intestinal epithelial cells. We believe these studies will further
our understanding of the development of host defense during
postpartum gut maturation. A better understanding of these
mechanisms may help to plan strategies for prevention.
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